FilingSEC EDGAR8-K
Valion Bio to effect 1-for-25 reverse stock split to maintain Nasdaq listing.
· SEC accepted
StagePending
Filing content
The company will implement a 1-for-25 reverse stock split effective August 31, 2026, to regain compliance with Nasdaq's minimum bid price requirement.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…